biogenics received $300 million to offset the cost of developing a virus vaccine for the...
60.1K
Verified Solution
Link Copied!
Question
Accounting
biogenics received $300 million to offset the cost of developing a virus vaccine for the usda. they spent $61 million on research and $498 million on phase i - iii trials. manufacturing will cost $.10 per dose for the 300 million doses being produced. how much will the price per dose have to be in order to cover all the costs and leave biogenics with a profit of $153 million?
Answer & Explanation
Solved by verified expert
Get Answers to Unlimited Questions
Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!
Membership Benefits:
Unlimited Question Access with detailed Answers
Zin AI - 3 Million Words
10 Dall-E 3 Images
20 Plot Generations
Conversation with Dialogue Memory
No Ads, Ever!
Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
